glp-1 medications tirzepatide for Weight Loss: Semaglutide vs vs Retat – Revolution Health & Wellness Weighing benefits, risks of GLP-1

Diarrhea or Constipation: Changes in how quickly the stomach and intestines move food can lead to bowel habit changes

SURMOUNT Weight Loss Trials The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity or overweight without diabetes

GIP adds effects on insulin sensitivity and fat and sugar metabolism

Food and Drug Administration (FDA) has approved Eli Lilly and Companys tirzepatide injections for chronic weight management in adult patients who are obese, overweight or present with at least one weight-related condition such as high blood pressure or high cholesterol

The fastest weight loss typically occurs between weeks 8 and 20 of treatment, precisely when the dose is climbing from 5mg to 10mg or higher